Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong
· Delayed Price · Currency is HKD 36.86
-0.44 (-1.18%)
Apr 29, 2026, 4:08 PM HKT
HKG:3692 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 226,148 | 218,427 | 102,545 | 93,358 | 87,864 | 112,525 | Upgrade
|
| Market Cap Growth | 55.86% | 113.00% | 9.84% | 6.25% | -21.92% | -49.44% | Upgrade
|
| Enterprise Value | 191,138 | 188,836 | 77,426 | 72,847 | 68,167 | 95,387 | Upgrade
|
| Last Close Price | 37.30 | 36.08 | 17.09 | 15.30 | 14.25 | 18.06 | Upgrade
|
| PE Ratio | 36.08 | 35.33 | 22.04 | 25.86 | 30.08 | 33.79 | Upgrade
|
| Forward PE | 33.01 | 36.29 | 24.05 | 28.31 | 24.97 | 27.09 | Upgrade
|
| PS Ratio | 13.52 | 13.06 | 7.86 | 8.39 | 8.28 | 9.23 | Upgrade
|
| PB Ratio | 5.75 | 5.55 | 3.36 | 3.29 | 3.43 | 4.58 | Upgrade
|
| P/TBV Ratio | 5.81 | 5.61 | 3.39 | 3.31 | 3.44 | 4.58 | Upgrade
|
| P/FCF Ratio | - | - | 26.47 | 29.25 | 31.49 | 43.30 | Upgrade
|
| P/OCF Ratio | - | - | 24.95 | 27.19 | 28.35 | 35.57 | Upgrade
|
| PEG Ratio | 4.96 | 4.18 | 3.63 | 3.12 | 1.56 | 1.11 | Upgrade
|
| EV/Sales Ratio | 11.43 | 11.29 | 5.93 | 6.54 | 6.43 | 7.82 | Upgrade
|
| EV/EBITDA Ratio | 29.73 | 29.38 | 17.01 | 21.86 | 20.57 | 25.20 | Upgrade
|
| EV/EBIT Ratio | 31.80 | 31.42 | 18.65 | 24.68 | 23.13 | 27.55 | Upgrade
|
| EV/FCF Ratio | - | - | 19.99 | 22.83 | 24.43 | 36.71 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.17 | 0.19 | 0.19 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.02 | 0.03 | 1.41 | 1.48 | 1.24 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.03 | 1.49 | 1.77 | 1.81 | Upgrade
|
| Net Debt / Equity Ratio | -0.89 | -0.89 | -0.81 | -0.80 | -0.76 | -0.75 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.45 | -5.45 | -5.45 | -6.80 | -5.88 | -4.90 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -6.40 | -7.10 | -6.99 | -7.14 | Upgrade
|
| Asset Turnover | 0.42 | 0.42 | 0.38 | 0.32 | 0.33 | 0.41 | Upgrade
|
| Inventory Turnover | 2.41 | 2.41 | 1.82 | 2.02 | 2.03 | 2.46 | Upgrade
|
| Quick Ratio | 7.88 | 7.88 | 9.90 | 4.11 | 9.64 | 7.50 | Upgrade
|
| Current Ratio | 8.09 | 8.09 | 10.18 | 4.21 | 9.86 | 7.67 | Upgrade
|
| Return on Equity (ROE) | 17.35% | 17.35% | 16.05% | 13.53% | 12.11% | 14.31% | Upgrade
|
| Return on Assets (ROA) | 9.44% | 9.44% | 7.54% | 5.31% | 5.70% | 7.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 117.36% | 98.70% | 63.34% | 43.96% | 44.33% | 50.64% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.20% | 15.20% | 13.50% | 10.20% | 9.50% | 11.70% | Upgrade
|
| Earnings Yield | 2.73% | 2.83% | 4.54% | 3.87% | 3.32% | 2.96% | Upgrade
|
| FCF Yield | - | - | 3.78% | 3.42% | 3.18% | 2.31% | Upgrade
|
| Dividend Yield | 1.16% | 1.20% | 1.97% | 1.39% | 0.70% | 0.50% | Upgrade
|
| Payout Ratio | - | - | 42.51% | 19.90% | 27.56% | 14.04% | Upgrade
|
| Buyback Yield / Dilution | -0.52% | -0.52% | 1.16% | -1.52% | 1.14% | -2.04% | Upgrade
|
| Total Shareholder Return | 0.60% | 0.68% | 3.13% | -0.13% | 1.84% | -1.54% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.